Early rumors that British pharma giant AstraZeneca's chief executive, Pascal Soriot, was considering jumping ship to the major (and troubled)
generic drug manufacturer Teva sent the biopharma world into a tizzy.
Not exact matches
The world's largest
drug manufacturer is facing steep competition from a slew of smaller
generic players, and the recent loss of patent protection on its major branded
drug, Copaxone, is threatening
Teva's profit margins.
They visited: Sonny's Enterprises, largest car wash
manufacturer in the United States; City Furniture, one million square foot corporate headquarters and distribution center; Sprout Loud and Rex 3, largest commercial printer in South Florida - high growth internet company; Marine Association of South Florida (MASF), 7 billion dollar industry in South Florida - Tour of Roscioli and Water Taxi on New River (view existing working Marinas); Mario Portillo - Actavis (soon to be
Teva), largest
generic drug manufacturer in the world; and Broward Health - Cora E. Braynon Family Center, health care professions.